Should I buy Globe Life (GL) stock or is it too late?

Globe Life · Financials · price $166

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Keefe, Bruyette & Woods — 67% of its targets hit on this sector (497 calls tested). It aims for $190 (+15 %), call made on July 25, 2026, maturing on July 25, 2027 (81 d ago).

The 5 reliable analysts $197+19 %

The 4 other firms $181+8.7 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $197 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Globe Life

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	91 %	+36.7 %	11	$191 +15%
Keefe, Bruyette & Woods	100 %	+33.3 %	7	$190 +14%
Piper Sandler	92 %	+22.5 %	12	$200 +20%
JP Morgan	67 %	+9.2 %	12	$201 +21%
Morgan Stanley	32 %	-2.9 %	28	$197 +19%
Raymond James	83 %	+13.0 %	6	—
Credit Suisse	40 %	-1.6 %	5	—

In short — Should you invest in Globe Life? Is it too late, still worth it? Analysts are fairly positive (78% buy, median target $191, i.e. +15%), and the most reliable on GL targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

78% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
Median price target $191, i.e. +15% from the current price ($166).
The most reliable firm on GL, Keefe, Bruyette & Woods (100% hit rate, 7 scored calls), targets $190 (call made on July 24, 2026, maturing on July 24, 2027) (+14%) in its most recent call, and $162 (call made on October 28, 2025, maturing on October 28, 2026) (-2%) in the one coming due soonest.
5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
Reasonable valuation (P/E ~11) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 2 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on GL

Median target $191 (+15%) · 9 ratings · Buy consensus

Strong Buy00%

Buy778%

Hold222%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Globe Life now?

We won't decide for you. The facts: 78% of analysts rate it a buy, median target $191 (+15%), and Keefe, Bruyette & Woods (most reliable on GL, 100%) targets $190. Weigh that against valuation (P/E ~11). This is not personalized advice.

Is it too late to invest in Globe Life?

Not according to analysts: the median target ($191) is still +15% above the current price ($166) (most reliable on GL: Keefe, Bruyette & Woods, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Globe Life still worth investing in?

It depends on the gap between the price ($166) and its estimated value: analysts target $191 on median (+15%), with 78% buys (most reliable on GL: Keefe, Bruyette & Woods, 100%). Cross-check with their real reliability on GL and the cautions above. Information, not advice.

What's the main risk in buying GL?

The consensus is not unanimous: of 9 ratings, 2 are neutral.

→ Go deeper: the full Globe Life profile (consensus, analyst reliability, price target, performance).